ABOUT US
Global access to health innovations
Many people cannot access innovations in health that could improve or even save their lives. We believe that people should be able to access essential healthcare they need, no matter where they were born. And in an interconnected world, we know that disease anywhere can be a threat everywhere. That’s why Global Access Health uses a new business model to combine the best of science, business and philanthropy to bring better innovations in healthcare to more people around the world.
A new model for innovation in health
Global Access Health is a beyond-profit biotechnology company. We’re the first to commit our profits to providing community access to affordable state-of-the-art medical technology, in particular for the Global South.
We re-invest proceeds from commercial activities to support our primary goal of expanding access to affordable, high quality diagnostics and medical solutions to underserved communities.
We focus on expanding community access beyond the clinical care setting through decentralized research, development, and manufacturing.
Read below how we are starting with diagnostics.
OUR FIRST PORTFOLIO COMPANY
Global Access Diagnostics
Global Access Diagnostics (GADx) is a leading developer and manufacturer of advanced lateral flow and rapid diagnostic technologies. Leveraging our core technology platforms, we work with businesses, governments and international organisations, reinvesting our profits to deliver high quality and affordable diagnostics for everyone.
GADx also offers world-leading expertise for contract research and development as well as helping companies to scale-up manufacturing (prototyping to pilot-scale) and then facilitate local manufacturing and/or onward distribution throughout the world, with a focus on low and middle income countries.
Our approach is radically different
Re-investing profits in global health
We commercialize quality products and reinvest profits into the global health mission.
Radically open with intellectual property
We prioritize impact on end users over our bottom line, and are open to partnering with self-sustainable models.
Focus on responding to future pandemics
We develop diagnostics for emerging infectious diseases and build equitable solutions for rapid outbreak response.
Support local manufacturing capacity
We facilitate a network of production facilities and distributors to enable rapid affordable access in LMICs.
Get in touch
Get in touch with us now. Let’s explore how we can work together to strengthen community access to affordable medical technology and ensure that global health innovations reach the people that need it, everywhere.
Equitable access to high quality and affordable diagnostics and medicine for all.
TESTIMONIALS
What people are saying
“Global Access’ core business is the business of impact, focused on solving global health problems. Our dual mission requires that we maintain strong financial and operational discipline to deliver performance, not for the enrichment of equity holders, but to provide the resources and freedom that let us invest in driving impact. This model is not common but it can be successful in solving gaps that are not effectively addressed by other approaches.”
Sumin Koo
CEO
Global Access Health
“The pandemic was “an obvious call” to the importance of access to diagnostics. The lack of community access to affordable and effective diagnosis of COVID-19 (or other high-risk disease) makes the disease undetectable and resources directly unavailable to break the chain of transmission.”
Dan Wattendorf
Director of Innovation Technology Solutions
Gates Foundation
“The COVID-19 pandemic has painfully demonstrated the fundamental inequities in global public health, and in particular the crucial importance of access in low- and middle-income countries to low-price, high-quality life-saving diagnostic tools.”
Sean Hinton
CEO
Soros Economic Development Fund
